Summary
Alzheimer’s disease is an immutably progressing dementing disorder. Its major pathologic hallmark is the development of cytoskeletal changes in a few susceptible neuronal types. These changes do not occur inevitably with advancing age, but once the disease has begun, spontaneous recovery or remissions are not observed.
The initial cortical changes develop in the poorly myelinated transentorhinal region of the medial temporal lobe. The destructive process then follows a predictable pattern as it extends into other cortical areas. Location of the tanglebearing neurons and the severity of changes allow the distinction of six stages in disease propagation (transentorhinal stages I–II: clinically silent cases; limbic stages III-IV: incipient Alzheimer’s disease; neocortical stages V-VI: fully developed Alzheimer’s disease). A small number of cases display particularly early changes, indicating that advanced age is not a prerequisite for the evolution of the lesions. Alzheimer’s disease is thus an age-related, but not an agedependent, disease. The degree of brain destruction at stages III–IV often leads to the appearance of initial clinical symptoms, while stages V–VI represent fully developed Alzheimer’s disease. Assessment of stage V–VI cases allows estimation of the rate of prevalence of the disease.
The pattern of appearance of the neurofibrillary changes bears a striking resemblance to the inverse sequence of cortical myelination. Factors released by oligodendrocytes exert important influence upon nerve cells and suppress disordered neuritic outgrowth. The lack of such factors due to premature dysfunction of oligodendrocytes could contribute to imbalances in the neuronal cytoskeleton and eventually initiate the development of neurofibrillary changes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alexander GE, Crutcher MD, De Long MR (1990) Basal ganglia-thalamocortical circuits: parallel sub-strates for motor, oculomotor, “prefrontal” and “limbic” functions. Progr Brain Res 85: 119 – 146
Alzheimer A (1990) Über eine eigenartige Erkrankung der Hirnrinde. Centralbl Nervenheilk Psychiatr (Leipzig) 30: 177 – 179
Amaral DG (1987) Memory: anatomical organization of candidate brain regions. In: Brookhart JM, Mountcastle VB (eds) Handbook of physiology: The nervous system, V: Higher functions of the nervous system. 5th ed. Amer Physiol Soc, Bethesda, pp 211 – 294
Amaral DG, Insausti R (1990) Hippocampal formation. In: Paxinos E (ed) The human nervous system. Academic Press, New York, pp 711 – 756
Amaral DG, Price JL, Pitkänen A, Carmichael ST (1992) Anatomical organization of the primate amygdaloid complex. In: Aggleton JP (ed) The amygdala: Neurobiological aspects of emotion, memory, and mental dysfunction. Wiley-Liss, New York, pp 1 – 66
Arnold SE, Hyman BT, Flory J, Damasio AR, van Hoesen GW (1991) The topographical and neuroana-tomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cerebral Cortex 1: 103 – 116
Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992 a) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42: 631–639
Arriagada PV, Marzloff L, Hyman BT (1992b) Distribution of Alzheimer-type pathologic changes in non-demented elderly individuals matches the pattern in Alzheimer’s disease. Neurology 42: 1681 – 1688
Bachman DL, Wolf PA, Linn RT, Knoefel JE, Cobb JL, Belanger AJ, White LR, D’Agostino RB (1993) Incidence of dementia and probable Alzheimer’s disease in a general population: the Framingham study. Neurology 43: 515 – 519
Balazs L, Leon M (1994) Evidence of an oxidative challenge in the Alzheimer’s brain. Neurochem Res 19: 1131 – 1137
Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Wisniewski HM (1989) Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer’s disease. Brain Res 477: 90 – 99
Bancher C, Braak H, Fischer P, Jellinger KA (1993) Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer’s and Parkinson’s disease. Neurosci Lett 162: 179 – 182
Benzi G, Moretti A (1995) Are reactive oxygen species involved in Alzheimer’s disease? Neurobiol Aging 16: 661 – 674
Berg L, Morris JC (1994) Diagnosis. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer Disease. Raven Press, New York, pp 9 – 25
Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87: 554 – 567
Braak H (1980) Architectonics of the human telencephalic cortex. Springer, Berlin. Braak H,
Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82: 239 – 259
Braak H, Braak E (1994) Pathology of Alzheimer’s disease. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 585 – 613
Braak H, Braak E (1996) Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol. 92: 197 – 201
Braak H, Duyckaerts C, Braak E, Piette F (1993) Neuropathological staging of Alzheimer-related changes correlates with psychometrically assessed intellectual status. In: Corian B, Iqbal K, Nicolini M, Winblad B, Wisniewski H, Zatta P (eds) Alzheimer’s disease: Advances in Clinical and Basic Research. Third International Conference on Alzheimer’s Disease and Related Disorders. Wiley, Chichester, pp 131 – 137
Braak H, Braak E, Yilmazer D, de Vos RAI, Jansen ENH, Bohl J (1996) Pattern of brain destruction in Parkinson’s and Alzheimer’s diseases. J Neural Transm 103: 455 – 490
Brodmann K (1910) Feinere Anatomie des Großhirns. In: Lewandowsky M (ed) Handbuch der Neurologie, Vol. 1, Springer, Berlin, pp 206 – 307
Cadelli DS, Bandtlow CE, Schwab ME (1992) Oligodendrocyte- and myelin-associated inhibitors of neurite outgrowth: their involvement in the lack of CNS regeneration. Exp Neurol 115: 189 – 192
Choi BH (1995) Oxidative stress and Alzheimer’s disease. Neurobiol Aging 16: 675 – 678
Corey-Bloom J, Galasko D, Thal LJ (1994) Clinical features and natural history of Alzheimer’s disease. In: Calne DP (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 631 – 645
Corrada M, Brookmeyer R, Kawas C (1995) Sources of variability in prevalence rates of Alzheimer’s disease. Int J Epidemiol 24: 1000 – 1005
Damasio AR, Damasio H (1991) Disorders of higher brain function. In: Rosenberg RN (ed) Comprehensive neurology. Raven Press, New York, pp 639 – 657
Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen SH, Aronson MK (1991) Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13: 179 – 189
Dickson DW, Ksiezak-Reding H, Liu WK, Davies P, Crowe A, Yen S HC (1992) Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site. Acta Neuropathol 84: 596 – 605
Duyckaerts C, He Y, Seilhean D, Delaère P, Piette F, Braak H, Hauw JJ (1994) Diagnosis and staging of Alzheimer’s disease in a prospective study involving aged individuals. Neurobiol Aging 15 (Suppl 1): 140 – 141
Duyckaerts C, Delaère P, He Y, Camilleri S, Braak H, Piette F, Hauw JJ (1995) The relative merits of tau-and amyloid markers in the neuropathology of Alzheimer’s disease. In: Bergener M, Finkel SI (eds) Treating Alzheimer’s and other dementias. Springer, New York, pp 81 – 89
Ebly EM, Parhad IM, Hogan DB, Fung TS (1994) Prevalence and types of dementia in the very old: results from the Canadian study of health and aging. Neurology 44; 1593 – 1600
Felleman DJ, van Essen DC (1991) Distributed hierarchical processing in the primate cerebral cortex. Cerebral Cortex 1: 1 – 47
Flechsig P (1920) Anatomie des menschlichen Gehirns und Rückenmarks auf myelogenetischer Grundlage. Thieme, Leipzig
Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A (1995) The consortium to establish a registry for Alzheimer’s disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer’s disease. Neurology 45: 461 – 466
Goedert M (1993) Tau protein and the neurofibrillary pathology of Alzheimer’s disease. Trends Neurosci 16: 460 – 465
Goedert M, Spillantini MG, Crowther RA (1991) Tau proteins and neurofibrillary degeneration. Brain Pathol 1: 279 – 286
Hardy R, Reynolds R (1993) Neuron-oligodendroglial interactions during central nervous system development. J Neurosci Res 36: 121 – 126
Harrell LE, Callaway R, Powers R (1993) Autopsy in dementing illness: who participates? Alzheimer Dis Assoc Disord 7: 80 – 87
Heimer L, de Olmos J, Alheid GF, Zaborszky L (1991) “Perestroika” in the basal forebrain: opening the border between neurology and psychiatry. Progr Brain Res 87: 109–165
Hofman A, Rocca W, Brayne C (1991) The prevalence of dementia in Europe: a collaborative study of the 1980–1990 findings. Int J Epidemiol 20: 736 – 748
Hyman BT, van Hoesen GW, Damasio AR, Barnes CL (1984) Alzheimer’s disease: cell-specific pathology isolates the hippocampal formation. Science 225: 1168 – 1170
Hyman BT, van Hoesen GW, Damasio AR (1990) Memory-related neural systems in Alzheimer’s disease: an anatomic study. Neurology 40: 1721 – 1730
Hyman BT, Gomez-Isla T (1994) Alzheimer’s disease is a laminar, regional, and neural system specific disease, not a global brain disease. Neurobiol Aging 15: 353 – 354
Iqbal K, Alonso AC, Gong CX, Khatoon S, Singh TJ, Grundke-Iqbal I (1994) Mechanism of neurofibrillary degeneration in Alzheimer’s disease. Molecular Neurobiol 9: 119 – 123
Jellinger K, Braak H, Braak E, Fischer P (1991) Alzheimer lesions in the entorhinal region and isocortex in Parkinson’s and Alzheimer’s diseases. Ann New York Acad Sci 640: 203 – 209
Kapfhammer JP, Schwab ME (1994) Inverse patterns of myelination and GAP-43 expression in the adult CNS: Neurite growth inhibitors as regulators of neuronal plasticity. J Comp Neurol 340: 194 – 206
Katzman R, Kawas C (1994) The epidemiology of dementia and Alzheimer’s disease. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer’s disease. Raven Press, New York, pp 105 - 122
Kemper TL (1978) Senile dementia: a focal disease in the temporal lobe. In: Nandy E (ed) Senile dementia: a biomedical approach. Elsevier, Amsterdam, pp 105 – 113
Khachaturian ZS (1985) Diagnosis of Alzheimer’s disease. Arch Neurol 42: 1097 – 1105
Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer’s disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41: 479 – 486
Moossy J, Zubenko GS, Martinez AJ, Rao GR (1988) Bilateral symmetry of morphological lesions in Alzheimer’s disease. Arch Neurol 45: 251 – 254
Mortimer J (1988) Epidemiology of dementia: international comparisons. In: Brody JA, Maddox GL (eds) Epidemiology and aging: an international perspective. Springer, New York, pp 150 – 164
Ohm TG, Müller H, Braak H, Bohl J (1995) Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer’s disease-related neurofibrillary changes. Neuroscience 64: 209 – 217
Pandya DN, Yeterian EH (1990) Prefrontal cortex in relation to other cortical areas in rhesus monkey: architecture and connections. Progr Brain Res 85: 63 – 94
Pappolla MA, Omar RA, Kim KS, Robakis NK (1992) Immunohistochemical evidence of antioxidant stress in Alzheimer’s disease. Am J Pathol 140: 621 – 628
Price DL, Sisodia SS (1994) Cellular and molecular biology of Alzheimer’s disease and animal models. Ann Rev Med 45: 435 – 446
Price JL, Davis PB, Morris JC, White DL (1991) The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer’s disease. Neurobiol Aging 12: 295 – 312
Probst A, Langui D, Ulrich J (1991) Alzheimer’s disease: a description of the structural lesions. Brain Pathol 1: 229 – 239
Reisberg B, Ferris SH, Kluger A, Franssen E, DeLeon MJ, Mittelman M, Borenstein J, Rameshwar K, Alba R (1989) Symptomatic changes in CNS aging and dementia of the Alzheimer type: Cross-sectional, temporal, and remediable concomitants. In: Bergener M, Reisberg B (eds) Diagnosis and treatment of senile dementia. Springer, Berlin, pp 193 – 223
Reisberg B, Pattschull–Furlan A, Franssen E, Sclan SG, Kluger A, Dingcong L, Ferris SH (1992) Dementia of the Alzheimer type recapitulates ontogeny inversely on specific ordinal and temporal parameters. In: Kostovic I, Knezevic S, Wisniewski HM, Spillich GJ (eds) Neurodevelopment, aging and cognition. Birkhäuser, Boston, pp 345 – 369
Schwab ME (1990) Myelin-associated inhibitors of neurite growth and regeneration in the CNS. Trends Neurosci 13: 452 – 456
Squire LR, Zola-Morgan S (1988) Memory: brain systems and behavior. Trends Neurosci 11: 170–175
Squire LR, Zola-Morgan S (1991) The medial temporal lobe memory system. Science 253: 1380–1386
Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P (1988) The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer’s disease: a clinicopathologic study of 57 cases. Neurology 38: 359–364
Trojanowski JQ, Shin RW, Schmidt ML, Lee VMY (1995) Relationship between plaques, tangles, and dystrophic processes in Alzheimer’s disease. Neurobiol Aging 16: 335 – 340
van Hoesen GW, Hyman BT (1990) Hippocampal formation: anatomy and the patterns of pathology in Alzheimer’s disease. Progr Brain Res 83: 445 – 457
van Hoesen GW, Solodkin A (1993) Some modular features of temporal cortex in humans as revealed by pathological changes in Alzheimer’s disease. Cerebral Cortex 3: 465 – 475
van Hoesen GW, Hyman BT, Damasio AR (1991) Entorhinal cortex pathology in Alzheimer’s disease. Hippocampus 1: 1 – 8
Vaughan DW (1984) The structure of neuroglial cells. In: Jones EG, Peters A (eds) Cerebral cortex, vol. 2: Functional properties of cortical cells. Plenum Press, New York, pp 285 – 329
Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Monogue K, Cerami A (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer’s disease. Proc Natl Acad Sci USA 91: 4766 – 4770
Volicer L, Crino PB (1990) Involvement of free radicals in dementia of the Alzheimer’s type: a hypothesis. Neurobiol Aging 11: 567 – 571
Vogt C, Vogt O (1919) Allgemeinere Ergebnisse unserer Hirnforschung. J Psychol Neurol 25: 279 – 461
Yakovlev PI, Lecours AR (1967) The myelogenetic cycles of regional maturation of the brain. In: Minkowski A (ed) Regional development of the brain in early life. Blackwell, Oxford, pp 3 – 70
Zilles K (1990) Cortex: In: Paxinos G (ed) The human nervous system. Academic Press, New York, pp 757 – 802
Zola-Morgan S, Squire LR (1993) Neuroanatomy of memory. Ann Rev Neurosci 16: 547 – 563
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Braak, H., Braak, E. (1997). Aspects of Cortical Destruction in Alzheimer’s Disease. In: Hayman, B.T., Duyckaerts, C., Christen, Y. (eds) Connections, Cognition and Alzheimer’s Disease. Research and Perspectives in Alzheimer’s Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60680-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-60680-9_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64504-4
Online ISBN: 978-3-642-60680-9
eBook Packages: Springer Book Archive